COH29 T3157
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
COH29 is an orally available, aromatically substituted thiazole and inhibitor of the human ribonucleotide reductase (RNR), with potential antineoplastic activity. Upon oral administration, the RNR inhibitor COH29 binds to the ligand-binding pocket of the
CAS nr:
1190932-38-7
Purity:
98%
Molecular Weight:
420,44
SMILES:
c1c(ccc(c1O)O)C(=O)Nc1nc(c(s1)c1ccccc1)c1cc(c(cc1)O)O
Formula:
C22H16N2O5S
Pathway:
DNA Damage/DNA Repair,Cell Cycle/Checkpoint
Target:
DNA/RNA Synthesis,DNA/RNA Synthesis
